Literature DB >> 17006763

Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment.

Rukhsana Sultana1, D Allan Butterfield.   

Abstract

Mild cognitive impairment (MCI) is regarded as a transition stage between the cognitive changes of normal aging and the more serious problems caused by Alzheimer's disease (AD). Previous studies had demonstrated increased expression of cell cycle proteins in AD brain. In the present study, we have analyzed the expression of the cell cycle proteins, CDK2, CDK5 and cyclin G1 in hippocampus and inferior parietal lobule (IPL) in subjects with amnestic mild cognitive impairment and control using Western blot analysis. The expression of CDK2, CDK5 and cyclin G1 were found to be significantly increased in MCI hippocampus as well as in IPL compared to control brain. These results suggest that some cells may have re-entered the cell cycle. However, the expression of CDK2 and CDK5 is greater in MCI hippocampus compared to those of MCI IPL, and hippocampus is a region that is severely affected by AD pathology. Since these proteins are involved directly or indirectly in microtubule destabilization and hyperphosphorylation of tau, and also in APP processing we hypothesize that cell cycle disturbance may be important contributor in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006763     DOI: 10.1007/s11064-006-9123-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  57 in total

1.  Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.

Authors:  K Iijima; K Ando; S Takeda; Y Satoh; T Seki; S Itohara; P Greengard; Y Kirino; A C Nairn; T Suzuki
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

Review 2.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

3.  The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity.

Authors:  M L Smith; H U Kontny; R Bortnick; A J Fornace
Journal:  Exp Cell Res       Date:  1997-01-10       Impact factor: 3.905

4.  Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus.

Authors:  Max Holzer; Ulrich Gärtner; Andrea Stöbe; Wolfgang Härtig; Hildegard Gruschka; Martina K Brückner; Thomas Arendt
Journal:  Acta Neuropathol       Date:  2002-07-03       Impact factor: 17.088

5.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Authors:  A McShea; P L Harris; K R Webster; A F Wahl; M A Smith
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

6.  Identification of CIP-1-associated regulator of cyclin B (CARB), a novel p21-binding protein acting in the G2 phase of the cell cycle.

Authors:  A McShea; T Samuel; J T Eppel; D A Galloway; J O Funk
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

7.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein.

Authors:  Shinya H Kimura; Hiroshi Nojima
Journal:  Genes Cells       Date:  2002-08       Impact factor: 1.891

9.  Ethanol-induced alteration in N-methyl-D-aspartate receptor 2A C-terminus and protein kinase C activity in rat brain.

Authors:  Rukhsana Sultana; Phanithi Prakash Babu
Journal:  Neurosci Lett       Date:  2003-09-25       Impact factor: 3.046

10.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R Markesbery
Journal:  Neurobiol Dis       Date:  2006-02-08       Impact factor: 5.996

View more
  23 in total

1.  CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury.

Authors:  Shruti V Kabadi; Bogdan A Stoica; David J Loane; Tao Luo; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

2.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

3.  Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Jonathan Miller; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

Review 4.  Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease.

Authors:  Jeriel T R Keeney; Aaron M Swomley; Jessica L Harris; Ada Fiorini; Mihail I Mitov; Marzia Perluigi; Rukhsana Sultana; D Allan Butterfield
Journal:  Neurotox Res       Date:  2011-11-15       Impact factor: 3.911

Review 5.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

6.  Comparison of ionized calcium-binding adapter molecule 1 immunoreactivity of the hippocampal dentate gyrus and CA1 region in adult and aged dogs.

Authors:  In Koo Hwang; Choong Hyun Lee; Hua Li; Ki-Yeon Yoo; Jung Hoon Choi; Dae Won Kim; Dong-Woo Kim; Hong-Won Suh; Moo-Ho Won
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

Review 7.  Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2012-10-05       Impact factor: 7.376

8.  Targeting Cdk5 activity in neuronal degeneration and regeneration.

Authors:  Jyotshnabala Kanungo; Ya-li Zheng; Niranjana D Amin; Harish C Pant
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

9.  Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.

Authors:  Genell D Hilton; Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-09       Impact factor: 6.200

Review 10.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.